First report of outcomes in patients with stage IIIb AL amyloidosis treated with Dara-VCD front-line therapy

Chakraborty, R., Rosenbaum, C., Kaur, G., Bhutani, D., Radhakrishnan, J., Mapara, M. Y., Maurer, M., & Lentzsch, S. (2023). First report of outcomes in patients with stage IIIb AL amyloidosis treated with Dara–VCD front‐line therapy. British Journal of Haematology, 201(5), 913–916. Portico. https://doi.org/10.1111/bjh.18733
Authors:
Rajshekhar Chakraborty
Cara Rosenbaum
Gurbakhash Kaur
Divaya Bhutani
Jai Radhakrishnan
Markus Y Mapara
Mathew Maurer
Suzanne Lentzsch
Affiliated Authors:
Rajshekhar Chakraborty
Divaya Bhutani
Jai Radhakrishnan
Markus Y Mapara
Mathew Maurer
Suzanne Lentzsch
Author Keywords:
amyloidosis
daratumumab
heart failure
Publication Type:
Article
Unique ID:
10.1111/bjh.18733
PMID:
Publication Date:
Data Source:
PubMed

Record Created: